... and highly prevalent. Predominant observation is an elevation of LDL cholesterol in all PCOS patients. Decreased concentrations of HDL cholesterol are found in obese PCOS from the third decade of life onwards while triglycerides start to rise from the second decade of life. PCOS is associated with oxidative...

... to 10 days for about 3 h. 7–18 g LDL were actually removed per treatment and plasma LDL cholesterol of 8 patients decreased about 70% during each procedure. The average loss of about 130 g of LDL cholesterol over a 9-month treatment period exceeds that reported for extensive plasma exchange therapy...

.... Direct testing of varying degrees of low-density lipoprotein (LDL)-cholesterol lowering has now been carried out in 4 large outcomes trials: PROVE IT-TIMI 22, Ato Z, TNT and IDEAL. However, the question whether more aggressive LDL-cholesterol loweringby high-dose statins monotherapy is an appropriate...

... lipoprotein (LDL) cholesterol predict an increased risk for early manifestation of cardiovascular diseases and increased early mortality. Elevated LDL cholesterol in childhood induces early development of vascular damage and decreased vascular distensibility. Healthy lifestyles and dietary habits...

... Familial hypercholesterolemia LDL cholesterol Dietary treatment Saturated fat Plant sterols Key Messages • Children with severe hypercholesterolemia should be diagnosed and treated early to reduce the risk for premature cardiovascular morbidity and mortality • Dietary...

... version of its guidelines [ 6 ]. In the guidelines, JAS changed the former diagnostic criteria of hyper-cholesterolemia (total cholesterol: 220 mg/dl, 5.7 m m ) described in the 2004 version [ 4 ] to 140 mg/dl (3.6 m m ) of low-density lipoprotein (LDL) cholesterol, and JAS no longer used total...

... (LDL) -cholesterol, apolipoprotein B levels, and markedly increased triglyceride and lipoprotein(a) levels. It may be advisable to measure apolipoprotein B level in PD patients as the LDL-cholesterol level cannot always be calculated using the Fridewald equation because of marked hypertriglyceridemia...

... lipoproteins (HDL) rather than a high LDL [ 1 , 2 ]. Stage 5 chronic kidney disease (CKD) patients on dialysis are at very high absolute risk for heart disease. Therefore, it was assumed that the greatest absolute benefit could be obtained by LDL-cholesterol lowering treatment in these patients...

... in the general population and in patients with end-stage renal disease (ESRD) . HD patients usually present with an atherogenic profile characterized by relatively normal total cholesterol (TC) and LDL-cholesterol (LDL-C) accompanied by high triglyceride (TG) , low HDL-cholesterol (HDL-C), moderately increased...

... have revealed that ‘these are effective in lowering LDL levels but are essentially ineffective in preventing atherosclerotic diseases’ [ 2 ]. With these developments as a background, the Japan Society for Lipid Nutrition established a committee on new cholesterol guidelines aimed at changing...

... Cardiovascular disease Dietary patterns LDL cholesterol HDL cholesterol Triglycerides Blood glucose Key Messages • The risk factors that drive cardiovascular disease (CVD) such as elevated LDL cholesterol and dyslipidemia, hypertension and impaired glucose tolerance, are largely...

... on plasma lipids and lipoproteins in uraemic patients. Ann Med 1994;26:271-282 3. Baigent C, Landray MJ, Reith C: , et al The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled...

... complication of the animal studies is that most animal species have high-density lipoprotein (HDL) as the major plasma cholesterol carrier as compared with humans where low-density lipoprotein (LDL) cholesterol constitutes some 65% of the plasma cholesterol. In addition, few animal species have comparable...